title: Protection of isolated rat heart from oxidative stress by exogenous creatine phosphate.
abstract: The influence of exogenous creatine phosphate (CP) on peroxidative heart injury was investigated in two experimental models: isolated working rat hearts and myocardial membrane preparations. In the first model the addition of 190 microM hydrogen peroxide to the perfusion buffer caused a marked decrease of aortic flow, minute work and peak aortic pressure, and leakage of intracellular enzymes. In the presence of 10 mM CP the hemodynamic damage produced by the same concentration of hydrogen peroxide was significantly lower and enzyme release was also remarkably reduced. The protection was concentration-dependent and the whole structure of the molecule was required since creatine was found to be ineffective. In the absence of hydrogen peroxide, CP and creatine did not affect heart performance. In microsomal membrane preparations CP decreased the formation of thiobarbituric acid-reactive material (malonaldehyde) induced by hydrogen peroxide in the presence of ferrous ions. This protection was concentration-dependent and occurred at physiological concentrations of CP. Also in this experimental model creatine had no effect and creatine plus inorganic phosphate was much less active than CP. The influence of CP on oxidative heart stress could account for the beneficial effect of this substance in different models of ischemic injury.
authors.affiliation: Department of Cardiology, University of Pisa, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Zucchi
authors.forename: R
authors.initials: R
authors.lastname: Poddighe
authors.forename: U
authors.initials: U
authors.lastname: Limbruno
authors.forename: M
authors.initials: M
authors.lastname: Mariani
authors.forename: S
authors.initials: S
authors.lastname: Ronca-Testoni
authors.forename: G
authors.initials: G
authors.lastname: Ronca
mesh_terms: D000818:Animals; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology; D003401:Creatine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects; D006861:Hydrogen Peroxide / Q000633:toxicity; D000860:Hypoxia / Q000188:drug therapy / Q000503:physiopathology; D066298:In Vitro Techniques; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008563:Membrane Lipids / Q000378:metabolism; D010725:Phosphocreatine / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013312:Stress, Physiological / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D008563:Membrane Lipids; D010725:Phosphocreatine; D006861:Hydrogen Peroxide; D003401:Creatine